Pharmaceuticals
News Releases
2014
December
Pharmaceuticals
ARIAD and Otsuka Announced Co-development and Commercialization Agreement for Iclusig® to Treat Leukemias in Japan and Nine Other Asian Countries
Nutraceuticals
Otsuka Pharmaceutical Saga Nutraceuticals Research Institute Strengthens Focus on Sports Nutrition Completion of New Artificial Environment Control Room
Nutraceuticals
Otsuka Pharmaceutical Acquired US-based FoodState Inc. Growing Supplement Business Through New Channels
Pharmaceuticals
Otsuka And Lundbeck's Brexpiprazole Demonstrates Statistically Significant Effects In New Phase III Studies In Adult Patients With Schizophrenia Presented At The American College Of Neuropsychopharmacology Annual Meeting
Pharmaceuticals
Otsuka And Lundbeck Present Phase III Data on Brexpiprazole As Adjunctive Therapy In Adult Patients With Major Depression At The American College Of Neuropsychopharmacology Annual Meeting
Pharmaceuticals
U.S. FDA Approves The Labeling Update Of Abilify Maintena ® (Aripiprazole) For Extended-Release Injectable Suspension To Describe New Clinical Data For The Treatment Of Acutely Relapsed Adults With Schizophrenia
Corporate
Otsuka Pharmaceutical To Acquire Avanir Pharmaceuticals (PDF: 420.2 KB)
November
Pharmaceuticals
L-Cartin® FF Tablets For Carnitine Deficiencies To Be Introduced in Japan on December 5 Active Ingredient Carnitine in Free Form (FF*) to Address the Needs of Medical Field
Nutraceuticals
Nutrition & Santé Inaugurates New Factory Expanding Production Base of the French Leader in Functional and Dietetic Foods
Corporate
Otsuka Group Establishes New Company in Order to Strengthen Presence in Vending Machine Market
Corporate
Otsuka Pharmaceutical Tokushima Itano Factory Cosponsors 6th Asan Walking Festival in Itano Environmentally And Human-friendly Facility Maintains Close Ties to The Local Community
October
Nutraceuticals
New product for Japanese women Nature Made Fish Oil Pearl Small Pearl-shaped Capsules Concentrated With Essential Nutritional Balance of Fish Oil
Pharmaceuticals
Otsuka Pharmaceutical's QuickNavi™-Flu Influenza Diagnostic Kit to Provide Additional Diagnosis-Related Information
Nutraceuticals
Calorie Mate Recipient of "G Mark" Good Design Long Life Design Award
September
Pharmaceuticals
U.S. FDA Accepts Otsuka and Lundbeck's Filing for Review of Brexpiprazole for the Treatment of Schizophrenia and as Adjunctive Therapy for the Treatment of Major Depression
Nutraceuticals
Otsuka Pharmaceutical Launches "Next Generation Athlete Development Project" at the 17th Asian Games Junior athletes experience world-class atmosphere at Asia's largest competition
Pharmaceuticals
A Marker to Monitor Treatment Effectiveness For Chronic Myeloid Leukemia(CML) Approval in Japan for Otsuka's Major BCR-ABL mRNA Measurement Kit
Nutraceuticals
New Calorie Mate Block "Plain" First simple, unadorned flavor marks a return to Calorie Mate origins after 32 years
Nutraceuticals
New SoyCarat Chili Pepper Flavor Spicy version of healthy, low GI soy snack packs grown-up appeal
Pharmaceuticals
A Change in the Treatment of Multidrug-Resistant Tuberculosis Begins New Antituberculosis Drug Deltyba® in 50 mg Tablets, Available to Patients in Japan Starting September 26
August
Nutraceuticals
Acquisition of Jasmine, Leading Brazilian Health Food Company
Nutraceuticals
UL･OS Announces New Skin Conditioner Promoting the Habit of Skin Care for Middle-Aged Men
Corporate
Otsuka Welfare Clinic for Refugees in Pakistan Awarded Foreign Minister's Commendation
Pharmaceuticals
E Keppra® 500 mg Injectable For Monotherapy Treatment of Epilepsy Submitted For Regulatory Review in Japan
July
Pharmaceuticals
Otsuka and Lundbeck Submit New Drug Application in The US for Brexpiprazole for The Treatment of Schizophrenia and as Adjunctive Therapy for The Treatment of Major Depressive Disorder
Pharmaceuticals
After 40 Years, A New Drug For The Treatment Of Tuberculosis In Japan Deltyba® (delamanid) Is The First Drug Approved In Japan Specifically For Pulmonary Multidrug-Resistant Tuberculosis (MDR-TB)
Pharmaceuticals
E Keppra® Injectable Receives Marketing Authorization in Japan Will Contribute to Uninterrupted Treatment of Epilepsy Patients Aged Four and Over
June
Pharmaceuticals
Regulatory Approval Received in Japan For L-Cartin® FF Tablets 100 mg・250 mg Doses That Incorporate Carnitine in Free Form (FF*) Enables Medical Professionals to Conveniently Switch Patients Among the Three Free-Form Formulations – Tablet, Oral Solution and Injection
Pharmaceuticals
Meptin®, a Fast-acting Bronchodilator to Treat Asthma and COPD, Will Become Available in Japan on July 2 in a New Form as Meptin® Swinghaler® 10μg 100Puffs
May
Pharmaceuticals
Launch in Japan of Samsca 30 mg Tablet Formulation for Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD), an Orphan Disease
Nutraceuticals
Otsuka Pharmaceutical Named the Major Official Sponsor of Inter-High School Athletic Championships for Two Consecutive Years Special Website Features Fan-produced Support Movies and First Streaming Broadcast of All Competitions
Nutraceuticals
Otsuka's POCARI SWEAT Aims the Very First Moon Landing Private Firms Take the Lead in the Start of "LUNAR DREAM CAPSULE PROJECT" Delivering all children's dreams 380,000KM to the moon
April
Pharmaceuticals
Otsuka Wins European Marketing Authorization for Deltyba™ (delamanid)
Nutraceuticals
New SOYJOY Almond & Chocolate Combines Crunchy Almonds, Subtly Sweet Chocolate and the Goodness of Soy The Perfect Snack for Busy Business People
Nutraceuticals
POCARI SWEAT ION WATER First Overseas Distribution Launched by King Car Otsuka in Taiwan
Pharmaceuticals
"QuickNavi Strep A" April 14 Market Launch in Japan Test Kit for the Rapid Detection of Group A Beta-hemolytic Streptococcal Antigen
March
Pharmaceuticals
Otsuka Acquires Rights to Hematological Cancer Treatment Dacogen® From Eisai (U.S.)
Pharmaceuticals
Otsuka and Takeda Announce a Co-promotion Agreement in Japan of TAK-438 For the Treatment of Acid-related Diseases in the Gastrointestinal Therapeutic Area
Pharmaceuticals
IBM and Otsuka Develop Transformative Care Coordination Solution
Nutraceuticals
On April 7, Otsuka Pharmaceutical Will Launch in Japan the Number-One Diet Food Product in France, "Milical"
Pharmaceuticals
Otsuka Pharmaceutical's Samsca® Approved in Japan as the World's First Drug Therapy for ADPKD, a Rare Kidney Disease
Nutraceuticals
Launch of EQUELLE Equol-containing food derived from soybeans A new option for women's health who are 40 and over during and after menopause
Pharmaceuticals
Anti-Epileptic Drug E Keppra® Filed in Japan for Additional Indication of Monotherapy for Partial-Onset Seizures
Corporate
Otsuka Pharmaceutical Opens a Second Day Care Center - the "Beanstalk Kids Center OSAKA" - at Otsuka's New Office Building in Osaka
Corporate
Otsuka Pharmaceutical was Awarded "Diversity Management Selection 100" from the Japan Ministry of Economy, Trade and Industry
February
Corporate
Agreement to Renew Memorandum of Understanding Between Otsuka Pharmaceutical and the Ministry of Health and Welfare of South Korea5-year extension of pharmaceutical research and development cooperation in South Korea
Pharmaceuticals
Otsuka's Antipsychotic Aripiprazole Awarded the 60th Okochi Memorial Prize
Nutraceuticals
Otsuka Pharmaceutical Supports the Tokyo Marathon 2014 Runners With Amino Value, the Official Beverage
Pharmaceuticals
Meptin Swinghaler, Easy-to-inhale Bronchodilator for COPD and Asthma Patients, Approved in Japan
Pharmaceuticals
Otsuka and Lundbeck Announce Once-Monthly Abilify Maintena™ Approved in Canada for the Maintenance Treatment of Schizophrenia in Stabilized Adult Patients
January
Pharmaceuticals
Otsuka and Lundbeck to present new data on brexpiprazole in major depressive disorder (MDD) at European Psychiatry Association 2014 Congress
Nutraceuticals
Otsuka Pharmaceutical's POCARI SWEAT to Be Official Drink for Two Consecutive Asian Games
Pharmaceuticals